The influence of 0.01% atropine on the choroidal vascular index and blood perfusion

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046587

Enrollment

Unknown

Registered

2021-05-22

Start date

2021-06-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

experimental group:0.01% atropine eyedrop

control group:Hydroxypropylcellulose dextran eye drops

Eligibility

Sex/Gender

All

Age

18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1.Adults aged 18-30 years, no gender limitation; 2.-6.00D=1.0; 3.Accommodative amplitude>=8.00D.

Exclusion criteria

Exclusion criteria: 1.Strabismus or amblyopia; 2.Previous eye operation or other chronic eye disease; 3.IOP>=21mmHg,binocular IOP difference>5mmHg; 4.Patients who have received the treatment of myopia control such as progressive multifocal soft mirror and cornea shaping mirror; 5.Systemic disease such as respiratory disease and cardiovascular disease; 6.Patients who are allergic to atropine; 7.Other factors that the researchers think it inappropriate to participate in the study.

Design outcomes

Primary

Measure	Time frame
Choroidal vascular index;Choroidal blood perfusion;	—

Countries

China

Contacts

Public ContactWu Hao

Eye Optometry Hospital Affiliated to Wenzhou Medical University

wuhao@eye.ac.cn+86 15958710273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026